Time Course of Microvascular Resistance of the Infarct and Noninfarct Coronary Artery Following an Anterior Wall Acute Myocardial Infarction
Overview
Affiliations
Previous studies have suggested that coronary flow velocity reserve (CFVR) in the early phase of acute myocardial infarction (AMI) is abnormal in infarcted and remote regions. This study determined the coronary microvascular resistance of infarct-related arteries (IRAs) and non-IRAs during AMI and at follow-up in patients who were treated with primary percutaneous intervention. In 73 patients with a first anterior wall AMI, baseline and minimal microvascular resistance in IRAs and non-IRAs immediately after reperfusion and at 1-week and 6-month follow-up were calculated as the ratio of mean transvascular pressure gradient to mean baseline and to adenosine-induced hyperemic blood flow velocity, respectively. CFVR in IRAs increased from 1.6 +/- 0.4 after reperfusion to 1.9 +/- 0.5 at 1 week and to 3.0 +/- 0.8 at 6 months (p <0.0001) and in non-IRAs from 2.4 +/- 0.5 to 2.7 +/- 0.6 at 1 week to 3.3 +/- 0.6 at 6 months (p <0.0001). Minimal microvascular resistance in IRAs and non-IRAs (3.2 +/- 1.7 and 2.2 +/- 0.6 mm Hg/second/cm, respectively) decreased significantly at follow-up (2.0 +/- 0.6 and 1.7 +/- 0.6 mm Hg/second/cm at 1 week and 1.8 +/- 0.6 and 1.8 +/- 0.7 mm Hg/second/cm at 6 months, respectively). After correction for rate-pressure product, baseline microvascular resistance after reperfusion and at 6 months did not significantly differ between IRAs and non-IRAs. In conclusion, minimal microvascular resistance is higher in infarcted and noninfarcted regions during AMI than at follow-up. The low CFVR in remote regions during AMI is probably due more to disturbed autoregulation than to increased myocardial workload.
Giga V, Tesic M, Beleslin B, Boskovic N, Sobic-Saranovic D, Jovanovic I Front Cardiovasc Med. 2023; 10:1196206.
PMID: 37771666 PMC: 10523777. DOI: 10.3389/fcvm.2023.1196206.
Coronary Microcirculation: The Next Frontier in the Management of STEMI.
Milasinovic D, Nedeljkovic O, Maksimovic R, Sobic-Saranovic D, Dukic D, Zobenica V J Clin Med. 2023; 12(4).
PMID: 36836137 PMC: 9962942. DOI: 10.3390/jcm12041602.
Fineschi M, Verna E, Barioli A, Mezzapelle G, Bartolini D, Turiano G Front Cardiovasc Med. 2022; 9:1051174.
PMID: 36531736 PMC: 9755670. DOI: 10.3389/fcvm.2022.1051174.
Silva M, Paiva L, Teixeira R, Ferreira M, Goncalves L Front Cardiovasc Med. 2022; 9:1041444.
PMID: 36440005 PMC: 9691675. DOI: 10.3389/fcvm.2022.1041444.
Di Serafino L, Magliulo F, Esposito G Interv Cardiol. 2021; 16:e24.
PMID: 34400971 PMC: 8353546. DOI: 10.15420/icr.2020.28.